Improvement in patient-reported sleep in type 2 diabetes and prediabetes participants receiving a continuous care intervention with nutritional ketosis

被引:20
作者
Siegmann, Morgan J. [1 ,2 ,3 ]
Athinarayanan, Shaminie J. [4 ]
Hallberg, Sarah J. [4 ,5 ]
McKenzie, Amy L. [4 ]
Bhanpuri, Nasir H. [4 ]
Campbell, Wayne W. [6 ]
McCarter, James P. [4 ,7 ]
Phinney, Stephen D. [4 ]
Volek, Jeff S. [4 ,8 ]
Van Dort, Christa J. [1 ,2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA
[2] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA
[3] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA
[4] Virta Hlth, 535 Mission St, San Francisco, CA USA
[5] Indiana Univ Hlth Arnett, Lafayette, IN USA
[6] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA
[7] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
[8] Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA
关键词
Type; 2; diabetes; Prediabetes; Ketogenic diet; PSQI; Nutritional ketosis; EXCESSIVE DAYTIME SLEEPINESS; WEIGHT-LOSS; GLYCEMIC CONTROL; INSULIN-RESISTANCE; KETOGENIC DIET; OBESE-PATIENTS; QUALITY; APNEA; CHOLECYSTOKININ; DURATION;
D O I
10.1016/j.sleep.2018.12.014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Sleep disruption is frequently associated with type 2 diabetes (T2D) and hyperglycemia. We recently reported the effectiveness of a continuous care intervention (CCI) emphasizing nutritional ketosis for improving HbA1c, body weight and cardiovascular risk factors in T2D patients. The present study assessed the effect of this CCI approach on sleep quality using a subjective patient-reported sleep questionnaire. Methods: A non-randomized, controlled longitudinal study; 262 T2D and 116 prediabetes patients enrolled in the CCI and 87 separately recruited T2D patients continued usual care (UC) treatment. Patients completed the Pittsburgh Sleep Quality Index (PSQI) questionnaire. A PSQI score of >5 (scale 0 to 21) was used to identify poor sleepers. Results: Global sleep quality improved in the CCI T2D (p < 0.001) and prediabetes (p < 0.001) patients after one year of intervention. Subjective sleep quality (component 1), sleep disturbance (component 5) and daytime dysfunction (component 7), also showed improvements in the CCI T2D (p < 0.01 for sleep quality and sleep disturbance; and p < 0.001 for daytime dysfunction) and prediabetes patients (p < 0.001 for all three components); compared to the UC T2D group after one year. The proportion of patients with poor sleep quality was significantly reduced after one year of CCI (T2D; from 68.3% at baseline to 56.5% at one year, p = 0.001 and prediabetes; from 77.9% at baseline to 48.7% at one year, p < 0.001). Conclusion: This study demonstrates improved sleep quality as assessed by PSQI in patients with T2D and prediabetes undergoing CCI including nutritional ketosis but not in T2D patients receiving UC. The dietary intervention benefited both sleep quality and the severity of T2D symptoms suggesting that nutritional ketosis improves overall health via multiple mechanisms. (c) 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:92 / 99
页数:8
相关论文
共 50 条
  • [31] Responsiveness of Patient-Reported Outcomes to Treatment Among Patients With Type 2 Diabetes Mellitus and OSA
    Donovan, Lucas M.
    Yu, Lan
    Bertisch, Suzanne M.
    Buysse, Daniel J.
    Rueschman, Michael
    Patel, Sanjay R.
    CHEST, 2020, 157 (03) : 665 - 672
  • [32] CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice
    Woo, Vincent
    Bell, Alan
    Clement, Maureen
    Noronha, Luis
    Tsoukas, Michael A.
    Camacho, Fernando
    Traina, Shana
    Georgijev, Natasha
    Rose, Jennifer B.
    Sorabji, Delna
    Bajaj, Harpreet S.
    CANADIAN JOURNAL OF DIABETES, 2019, 43 (07) : 464 - 471
  • [33] Improved patient-reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial
    Polonsky, William H.
    Giorgino, Francesco
    Rosenstock, Julio
    Whitmire, Katherine
    Lew, Elisheva
    Coudert, Mathieu
    Alvarez, Agustina
    Nicholls, Charlie
    McCrimmon, Rory J.
    DIABETES OBESITY & METABOLISM, 2022, 24 (12) : 2364 - 2372
  • [34] Development of an instrument for patient-reported outcomes in Thai patients with type 2 diabetes mellitus (PRO-DM-Thai)
    Chuayruang, Kanisshanone
    Sriratanaban, Jiruth
    Hiransuthikul, Narin
    Suwanwalaikorn, Sompongse
    ASIAN BIOMEDICINE, 2015, 9 (01) : 7 - 19
  • [35] Evaluation of patient-reported outcomes data in structured diabetes education intervention: 2-year follow-up data of patient empowerment programme
    Wong, Carlos K. H.
    Lam, Cindy L. K.
    Wan, Eric Y. F.
    Chan, Anca K. C.
    Pak, C. H.
    Chan, Frank W. K.
    Wong, William C. W.
    ENDOCRINE, 2016, 54 (02) : 422 - 432
  • [36] SPUR: A Patient-Reported Medication Adherence Model as a Predictor of Admission and Early Readmission in Patients Living with Type 2 Diabetes
    Wells, Joshua
    Wang, Chao
    Dolgin, Kevin
    Kayyali, Reem
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 441 - 455
  • [37] Involving children and adolescents with type 1 diabetes in health care: a qualitative study of the use of patient-reported outcomes
    Lassen, Rikke Bjerre
    Abild, Caroline Bruun
    Kristensen, Kurt
    Kristensen, Lene Juel
    Horluck, Jens Thusgard
    Jensen, Annesofie Lunde
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2023, 7 (01)
  • [38] Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes
    Lavikainen, Piia
    Aarnio, Emma
    Niskanen, Leo
    Mantyselka, Pekka
    Martikainen, Janne
    HEALTH POLICY, 2020, 124 (12) : 1310 - 1316
  • [39] Involving children and adolescents with type 1 diabetes in health care: a qualitative study of the use of patient-reported outcomes
    Rikke Bjerre Lassen
    Caroline Bruun Abild
    Kurt Kristensen
    Lene Juel Kristensen
    Jens Thusgård Hørlück
    Annesofie Lunde Jensen
    Journal of Patient-Reported Outcomes, 7
  • [40] Patient-Reported Outcomes with Insulin Glargine 300 U/mL in People with Type 2 Diabetes: The MAGE Multicenter Observational Study
    Colin, Ides M.
    Alexandre, Kathy
    Bruhwyler, Jacques
    Scheen, Andre
    Verhaegen, Ann
    DIABETES THERAPY, 2020, 11 (08) : 1835 - 1847